NCT05611827View on ClinicalTrials.gov

Pharmacological Profile of Different Quercetin Formulations

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

January 31, 2022

Primary Completion Date

July 31, 2022

Study Completion Date

October 31, 2022

Conditions
Pharmacokinetics
Interventions
DIETARY_SUPPLEMENT

Quercetin LipoMicel (250 mg)

Quercetin LipoMicel® soft-gels. Total dose of 250 mg of quercetin

DIETARY_SUPPLEMENT

Quercetin LipoMicel (500 mg)

Quercetin LipoMicel® soft-gels. Total dose of 500 mg of quercetin

DIETARY_SUPPLEMENT

Quercetin LipoMicel (1000 mg)

Quercetin LipoMicel® soft-gels. Total dose of 1000 mg of quercetin

DIETARY_SUPPLEMENT

Regular/standard Quercetin (500 mg)

Total dose of 500 mg of quercetin

Trial Locations (1)

V3N4S9

ISURA, Burnaby

All Listed Sponsors
lead

Factors Group of Nutritional Companies Inc.

INDUSTRY